Zolmitriptan Case Study

887 Words4 Pages

According to the information shown in Figure (6), liquisolid compacts technology with the assistance of non-volatile solvent was used for the preparation of liquisolid formulation of fast release tablets of Zolmitriptan. Zolmitriptan tablets are available in the market at doses of 2.5 mg and 5 mg . Dose of 2.5 mg was selected for the present study. Figure (6): Graphic representation of the preparation of liquisolid systems The preparation of the liquisolid systems involve the following steps: Firstly, the calculated quantities of Zolmitriptan and PG were precisely weighed and mixed together in 20 ml glass beaker, heated to 80 0 C in water bath sonicater for 15 minutes until homogenous drug solution of the liquid medication was obtained. After that, the resulting liquid solution (Zolmitriptan and PG ) was …show more content…

 Secondly, the obtained blend was uniformly spread as a homogeneous layer on the surface of the mortar and left standing for five minutes to allow the liquid medication to be absorbed inside powder particles.  Thirdly, the powder was scraped from mortar surface by means of a spatula and blended with a calculated quantity of superdisintegrant 5% (w/w) for 10 minutes. Sodium starch glycolate (SSG) was used in the all liquisolid formulations, then the final mixture was lubricated with 1% magnesium stearate for two minutes. Lastly, the prepared formulations were compressed manually into cylindrical tablets by using a single punch tablet press machine of die sizes measuring 6 and 8 mm. The optimized formulation with optimal R value, drug concentration and loading factor was determined according to the flow properties and in-vitro dissolution studies. 2.3.4.1 Flow Properties of the Prepared Liquisolid Powder

More about Zolmitriptan Case Study

Open Document